Biora Therapeutics, Inc.

NasdaqGM:BIOR Rapporto sulle azioni

Cap. di mercato: US$24.0m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Biora Therapeutics Gestione

Gestione criteri di controllo 3/4

Biora Therapeutics' CEO is Adi Mohanty, appointed in Nov 2021, has a tenure of 2.75 years. total yearly compensation is $3.14M, comprised of 18.3% salary and 81.7% bonuses, including company stock and options. directly owns 4.03% of the company’s shares, worth $967.37K. The average tenure of the management team and the board of directors is 2.5 years and 3.2 years respectively.

Informazioni chiave

Adi Mohanty

Amministratore delegato

US$3.1m

Compenso totale

Percentuale dello stipendio del CEO18.3%
Mandato del CEO2.8yrs
Proprietà del CEO4.0%
Durata media del management2.5yrs
Durata media del Consiglio di amministrazione3.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

Biora Therapeutics granted patent for oral delivery of GLP-1 receptor agonists

Sep 13

Biora Therapeutics: Checking In On The Transformation

Aug 17

Biora rallies 30%, highest since November on data for drug delivery device

Aug 10

Progenity: Analyzing The Huge Paradigm Shift

Dec 20

Progenity: Transformation Raises Questions

Oct 03

Progenity on a roller coaster ride since strategic transformation announcement

Jun 09

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Adi Mohanty rispetto agli utili di Biora Therapeutics?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$87m

Mar 31 2024n/an/a

-US$111m

Dec 31 2023US$3mUS$574k

-US$124m

Sep 30 2023n/an/a

-US$122m

Jun 30 2023n/an/a

-US$64m

Mar 31 2023n/an/a

-US$52m

Dec 31 2022US$4mUS$550k

-US$49m

Sep 30 2022n/an/a

-US$118m

Jun 30 2022n/an/a

-US$140m

Mar 31 2022n/an/a

-US$176m

Dec 31 2021US$10mUS$63k

-US$179m

Compensazione vs Mercato: Adi's total compensation ($USD3.14M) is above average for companies of similar size in the US market ($USD680.04K).

Compensazione vs guadagni: Adi's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Adi Mohanty (57 yo)

2.8yrs

Mandato

US$3,139,017

Compensazione

Mr. Aditya P. Mohanty, also known as Adi,M.B.A. serves as Chief Executive Officer and Director at Biora Therapeutics, Inc. (formerly known as Progenity, Inc.) since November 8, 2021. Mr. Mohanty founded En...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Aditya Mohanty
CEO & Director2.8yrsUS$3.14m4.03%
$ 967.4k
Eric d'Esparbes
Chief Financial Officer5.3yrsUS$1.60m1.58%
$ 379.3k
Clarke Neumann
Senior VP9.9yrsUS$1.53m1.28%
$ 306.7k
Eric Fox
VP of Finance & Accounting & Treasurerno dataNessun datoNessun dato
George Gianakopoulos
Senior Vice President of Sales4.8yrsNessun datoNessun dato
Robyn Hatton
Head of Human Resourcesno dataNessun datoNessun dato
Kevin Howe
Senior VP of Strategic Operationsno dataNessun datoNessun dato
Sharat Singh
Head of Research2.3yrsNessun datoNessun dato
Paul Shabram
Head of Technical Operations2.3yrsNessun datoNessun dato
Ariella Kelman
Chief Medical Officer1.3yrsNessun datoNessun dato
James Knight
Head of Business Developmentless than a yearNessun datoNessun dato

2.5yrs

Durata media

60yo

Età media

Gestione esperta: BIOR's management team is considered experienced (2.5 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Aditya Mohanty
CEO & Director2.8yrsUS$3.14m4.03%
$ 967.4k
Brian Kotzin
Independent Director5.2yrsUS$185.11k0.050%
$ 12.0k
William Chey
Member of Clinical Advisory Board SIBO & Functional Bowel Disordersno dataNessun datoNessun dato
Anthony Lembo
Member of Clinical Advisory Board SIBO & Functional Bowel Disordersno dataNessun datoNessun dato
Geert D'Haens
Member of Inflammatory Bowel Disease Clinical Advisory Board3.2yrsNessun datoNessun dato
Bruce Sands
Chairman of Inflammatory Bowel Disease Clinical Advisory Board3.2yrsNessun datoNessun dato
Jeffrey Alter
Independent Chairman5.6yrsUS$208.11k0.052%
$ 12.5k
Mark Pimentel
Member of Clinical Advisory Board - SIBO & Functional Bowel Disordersno dataNessun datoNessun dato
Lynne Powell
Independent Director5.5yrsUS$163.11k0.050%
$ 12.0k
Severine Vermeire
Member of Inflammatory Bowel Disease Clinical Advisory Board3.2yrsNessun datoNessun dato
Jill Howe
Independent Director2.8yrsUS$180.11k0.049%
$ 11.8k
Satish Rao
Chair of Clinical Advisory Board-SIBO/Functional Bowel Disordersno dataNessun datoNessun dato

3.2yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: BIOR's board of directors are considered experienced (3.2 years average tenure).